Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.2950 (-0.68%) ($7.0900 - $7.2950) on Fri. Jun. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.78% (three month average) | RSI | 71 | Latest Price | $7.2950(-0.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 7.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 12.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(37%) ARKK(35%) IBB(35%) ARKG(33%) XAR(33%) | Factors Impacting ATRA price | ATRA will decline at least -2.89% in a week (0% probabilities). VIXM(-71%) VXX(-32%) UNG(-27%) USO(-22%) XOP(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.89% (StdDev 5.78%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.77(7.75%) | 10 Day Moving Average | $6.04(20.78%) | 20 Day Moving Average | $5.65(29.12%) | To recent high | -25.7% | To recent low | 55.5% | Market Cap | $542m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |